#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Amyotrophic lateral sclerosis gene carrier Exudative retinopathy Cardiac sarcoidosis Myeloid leukaemia Primary amyloidosis Hidradenitis Fusarium infection Encephalitis autoimmune Thromboangiitis obliterans Oesophageal squamous cell carcinoma stage II Dupuytren's contracture Transitional cell carcinoma Peritoneal neoplasm Osteochondrodysplasia More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Trials in Disease Pituitary-dependent Cushing’s syndrome – Basic Information Leukoencephalopathy Ornithine transcarbamoylase deficiency – Trials in Disease Congenital generalised lipodystrophy – Diagnostics Mucopolysaccharidosis – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Brain stem glioma – Life with Disease Hairy cell leukaemia recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenol, Liquefied Nemolizumab Izorlisib Mesilate Azd9550 Tobevibart Miglustat Dapansutrile Diclofenac Epolamine Timrepigene Emparvovec Sirolimus Lovastatin Sodium Chloride Bosentan Panitumumab Choriogonadotropin Alfa Lixisenatide Milvexian COBALAMIN Azenosertib A/H1N1 INFLUENZA VACCINE More therapies…

    Learn about Your Condition

    EGFR gene mutation Liver transplant White matter lesion Colitis Lichen planus Hyponatraemia Sickle cell disease Indolent systemic mastocytosis Cholangiosarcoma Biliary tract operation Gestational diabetes Type 2 diabetes mellitus Meniscus operation Stomatitis Candida infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Estonia

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    • Atrial fibrillation
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
  • Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Denmark Estonia Norway
  • Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed
    • Cisplatin
    • Gemcitabine
    Belgium Estonia France Germany Ireland Italy +5
  • Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Pembrolizumab
    Estonia Germany Greece Italy Latvia Lithuania +2
  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10
  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed
    • Carboplatin
    • Cisplatin
    Czechia Estonia France Germany Hungary Italy +6
Previous Page
1 … 23 24 25 26 27 … 31
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Dexamethasone Fluorouracil Risankizumab Oxaliplatin Hydrocortisone Prednisolone Cytarabine Durvalumab Upadacitinib Inclisiran Venetoclax Carboplatin Tocilizumab Etoposide Olaparib Prednisone Methotrexate Pneumococcal Polysaccharide Serotype 18C Mycophenolate Mofetil Pneumococcal Polysaccharide Serotype 6B Milvexian Calcium Folinate Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26) Pneumococcal Polysaccharide Serotype 19A Empasiprubart Pneumococcal Polysaccharide Serotype 7F Apixaban Folinic Acid Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adenocarcinoma of colon Adrenogenital syndrome Age-related macular degeneration Arteriosclerosis Atrial fibrillation Axial spondyloarthritis Bladder cancer Cardiac failure Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Coagulation factor X level Colitis ulcerative Colorectal cancer metastatic Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cytomegalovirus immunisation Dementia Alzheimer's type Dermatitis atopic Diabetic foot infection Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dyslipidaemia Emphysema Encephalopathy neonatal Endocrine ophthalmopathy Endometrial cancer Factor IX deficiency Factor VIII deficiency Focal segmental glomerulosclerosis Follicular lymphoma Gastric cancer Generalised anxiety disorder Glioblastoma multiforme Hepatocellular carcinoma Herpes simplex Herpes zoster Hormone-refractory prostate cancer Hypercholesterolaemia Idiopathic pulmonary fibrosis IgA nephropathy Influenza Influenza immunisation Interstitial lung disease Lupus nephritis Macular oedema Major depression Mantle cell lymphoma Metapneumovirus infection Metastatic malignant melanoma Microsatellite instability cancer Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Neonatal asphyxia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Obesity Oesophageal adenocarcinoma Oesophageal carcinoma Orthostatic hypotension Osteoarthritis Osteoporosis postmenopausal Overweight Paroxysmal nocturnal haemoglobinuria PD-L1 positive cancer Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumonia Pneumonia respiratory syncytial viral Primary biliary cholangitis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer recurrent Psoriasis Psoriatic arthropathy Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal disorder Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal vein occlusion Rheumatoid arthritis Richter's syndrome Secondary progressive multiple sclerosis Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Systemic lupus erythematosus Thrombosis prophylaxis Type 1 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!